These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 15175963

  • 1. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B, Tröger A, Glouchkova L, Körholz D, Göbel U, Dilloo D.
    Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
    [Abstract] [Full Text] [Related]

  • 2. Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors.
    Suminoe A, Matsuzaki A, Hattori H, Koga Y, Hara T.
    Pediatr Transplant; 2009 Sep; 13(6):746-53. PubMed ID: 19067917
    [Abstract] [Full Text] [Related]

  • 3. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
    Shilyansky J, Jacobs P, Doffek K, Sugg SL.
    J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
    Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ.
    Cancer Res; 2004 Jul 15; 64(14):4973-9. PubMed ID: 15256471
    [Abstract] [Full Text] [Related]

  • 5. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N, Haicheur N, Massicard S, Vernel-Pauillac F, Adotevi O, Landais D, Gorin I, Robert C, Prince HM, Grob JJ, Leccia MT, Lesimple T, Wijdenes J, Bartholeyns J, Fridman WH, Salcedo M, Ferries E, Tartour E.
    J Immunother; 2008 Jan 15; 31(1):101-12. PubMed ID: 18157017
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 15; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 7. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B, Siegel SE, Kaiser HE.
    In Vivo; 2004 Dec 15; 18(1):81-100. PubMed ID: 15011756
    [Abstract] [Full Text] [Related]

  • 8. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma.
    Caruso DA, Orme LM, Amor GM, Neale AM, Radcliff FJ, Downie P, Tang ML, Ashley DM.
    Cancer; 2005 Mar 15; 103(6):1280-91. PubMed ID: 15693021
    [Abstract] [Full Text] [Related]

  • 9. Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.
    Weigel BJ, Panoskaltsis-Mortari A, Diers M, Garcia M, Lees C, Krieg AM, Chen W, Blazar BR.
    Exp Hematol; 2006 Oct 15; 34(10):1403-12. PubMed ID: 16982333
    [Abstract] [Full Text] [Related]

  • 10. In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors.
    Bönig H, Laws HJ, Wundes A, Verheyen J, Hannen M, Kim YM, Banning U, Nürnberger W, Körholz D.
    Bone Marrow Transplant; 2000 Jul 15; 26(1):91-6. PubMed ID: 10918410
    [Abstract] [Full Text] [Related]

  • 11. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA, Neelapu SS, Kwak LW, Biragyn A.
    Haematologica; 2002 Sep 15; 87(9):989-1001. PubMed ID: 12217812
    [Abstract] [Full Text] [Related]

  • 12. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
    Chang GC, Lan HC, Juang SH, Wu YC, Lee HC, Hung YM, Yang HY, Whang-Peng J, Liu KJ.
    Cancer; 2005 Feb 15; 103(4):763-71. PubMed ID: 15637694
    [Abstract] [Full Text] [Related]

  • 13. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 14. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J, Wang CL, Hao XS.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2785-90. PubMed ID: 18167273
    [Abstract] [Full Text] [Related]

  • 15. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD, Bellone S, Palmieri M, Ravaggi A, Romani C, Tassi R, Roman JJ, Burnett A, Pecorelli S, Cannon MJ.
    Gynecol Oncol; 2006 Mar 23; 100(3):469-78. PubMed ID: 16249018
    [Abstract] [Full Text] [Related]

  • 16. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S, Kimura T, Fujiki H, Nakagawa H, Ueda Y, Itoh T, Yamagishi H, Sonoda Y.
    Int J Oncol; 2007 Jun 23; 30(6):1461-8. PubMed ID: 17487367
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.
    Ueno H, Tcherepanova I, Reygrobellet O, Laughner E, Ventura C, Palucka AK, Banchereau J.
    J Immunol Methods; 2004 Feb 15; 285(2):171-80. PubMed ID: 14980432
    [Abstract] [Full Text] [Related]

  • 18. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y, Saxena A, Zheng C, Carlsen S, Xiang J.
    J Gene Med; 2004 Aug 15; 6(8):857-68. PubMed ID: 15293344
    [Abstract] [Full Text] [Related]

  • 19. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.
    Shurin GV, Shurin MR, Bykovskaia S, Shogan J, Lotze MT, Barksdale EM.
    Cancer Res; 2001 Jan 01; 61(1):363-9. PubMed ID: 11196188
    [Abstract] [Full Text] [Related]

  • 20. Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma.
    Jarnjak-Jankovic S, Pettersen RD, Saebøe-Larssen S, Wesenberg F, Olafsen MR, Gaudernack G.
    Cancer Gene Ther; 2005 Aug 01; 12(8):699-707. PubMed ID: 15846368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.